The 2019 edition of World Antibiotic Awareness Week (WAAW), a World Health Organization (WHO) Global Health campaign, will take place from November 18th – 24th.
bioMérieux is an active advocate of the responsible use of antibiotics.
We are committed to raising awareness on the prudent use of antibiotics and the global healthcare threat of antibiotic resistance.
Together, let’s optimize antibiotic use
Global-PPS HAI module
One of the ways we raise antibiotic awareness is by supporting the development of surveillance tools, such as the Global Point Prevalence Survey (Global-PPS).
The Global-PPS is a worldwide surveillance initiative that measures antimicrobial resistance and healthcare-associated infection (HAI) rates, as well as antibiotic consumption.
Measuring HAI rates is a critical part of any hospital’s Antimicrobial Stewardship Program.
Today, the new Global-PPS HAI module - a free and user-friendly survey tool - is available to hospitals worldwide.
Surveillance of HAIs just got easier!
What is the Global-PPS?
The Global-PPS is an annual survey coordinating surveillance of antimicrobial consumption, and HAI and resistance rates in hospitals worldwide.
In 2019, over 800 hospital networks in 50+ countries have taken part, gathering data on more than 250,000 patients.
The project is managed by the University of Antwerp (Belgium) and funded by bioMérieux.
What benefits does the HAI module offer for my hospital?
Want to know more about the HAI module? Watch the video below!
Diagnostics & Stewardship
In vitro diagnostic tests play an essential role in combatting the Antibiotic Resistance threat. Our extensive Antimicrobial Stewardship (AMS) diagnostics offer supports appropriate antibiotic use, helping to preserve their efficacy and curb antibiotic resistance.
It’s about having the right diagnostic tool to provide timely, relevant antimicrobial therapy information in every situation. See what just some of our AMS Diagnostic Solutions can do for you:
1. Deol P. et al. 2016; 26th ECCMID #EVO459
2. Lovern D., et al. Eur J Clin Microbiol Infect Dis., Dec 2016.
3. Rommler W., et al. Poster C-123, ASM Orlando, May 2006
4. Meisner M., et al. J Lab Med 1999;23:263-72
5. Schuetz P., et al. Crit care Med 2017 ; 45(5):781-789
6. Bouadma L., et al. Lancet 2010;375: DOI:10.1016/S0140-6736(09)61879-1
7. De Jong A., et al. The Lancet Infectious Diseases 2016 ; 16(7):819-827
8. Schuetz P., et al. Arch Intern Med 2011;171:1322-1331
BACT/ALERT® VIRTUO®, an automated instrument for faster blood culture
VITEK® 2, an automated identification and antibiotic susceptibility testing analyzer
VIDAS® B.R.A.H.M.S PCT™, automated test to determine procalcitonin (PCT), a specific marker of severe bacterial infection and sepsis
VITEK® MS, Mass spectrometry microbial identification system
BIOFIRE® FILMARRAY® PANELS, for syndromic testing with multiplex PCR system
WE ARE FOR
ADVANCING ANTIMICROBIAL STEWARDSHIP
FREE ACCREDITED WEBINAR!
“Value of Diagnostics in Antimicrobial Stewardship”
(An Asia-Pacific Outlook)
Dr Deborah Williamson is a Clinical Microbiologist and Deputy Director of the Microbiological Diagnostic Unit Public Health Laboratory (MDU PHL), Melbourne, Australia.
Dr David Lye is a Senior Consultant at the Institute of Infectious Diseases and Epidemiology (IIDE), Communicable Disease Centre, and Department of Infectious Diseases, Tan Tock Seng Hospital (TTSH), Singapore.
Learn more about Antimicrobial Resistance on bioMérieux’s dedicated website.
Dr. Deborah Williamson
MDU PHL, Australia
Dr. David Lye
bioMérieux has developed a collection of educational booklets on key Diagnostics/Healthcare topics. We invite you to download the selection below !
A practical guide to implementation in hospitals
Optimization through Drug Dosing and MIC
For diagnosis and guidance of antibiotic therapy
A key investigation for diagnosis of bloodstream infections